Abiopharma

🔍 Wendling Brian J (Executive)

Company: Liberty Broadband Corp (LBRDK)

Report Date: 2026-08-10

Detailed Transactions and Holdings:

• Acquired 1,461 shares of Series C Common Stock (Direct)
  Date: 2026-08-10 | Code: M | equity_swap_involved: 0 | shares_owned_after: 16,016.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 498 shares of Series C Common Stock at $35.88 per share (Direct)
  Date: 2026-08-10 | Code: F | equity_swap_involved: 0 | shares_owned_after: 15,518.00 | transaction_form_type: 4
• Sold 1,461 shares of Restricted Stock Units-LBRDK (Derivative)
  Date: 2026-08-10 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F3, F3

Footnotes:

• F1: Each restricted stock unit converted into one share of Series C Common Stock.
• F2: Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.
• F3: On November 12, 2024, the Issuer and Charter Communications, Inc. ("Charter"), among others, entered into an Agreement and Plan of Merger (the "Merger Agreement"). Pursuant to the Merger Agreement, restricted stock units of the Issuer shall automatically become fully vested, within 10 business days of the closing of the merger contemplated therein (the "Acceleration"). The Issuer and Charter entered into a consent letter pursuant to which the parties agreed to permit such Acceleration to occur within 10 business days of August 19, 2026.